Gene Therapy: Motivations for Research

Abstract

Genetics research, especially gene therapy research, might be seen as being conducted on behalf of those affected by the relevant disorders. However, the research process also might be motivated by the immediate concerns and circumstances of the researcher.

Keywords: gene therapy; ethics; publicity; investment; patient empowerment

References

Churchill L, Collins M, King N, Pemberton S and Wailoo K (1998) Genetic research as therapy: implications of ‘gene therapy’ for informed consent. Journal of Law, Medicine and Ethics 26(1): 38–47.

Duster T and Beeson D (1997) Pathways and Barriers to Genetic Testing: Molecular Genetics in the ‘High‐risk Family’. University of California, Berkeley, CA: Institute for the Study of Social Change.

Friedmann T (1996) Human gene therapy – an immature genie, but certainly out of the bottle. Nature Medicine 2: 144–147.

Gelsinger PL (2000) Statement to the United States Senate Health, Education, Labor and Pensions Subcommittee on Public Health, 2 February. http://www.senate.gov/∼labor/hearings/feb00hrg/020200wt/frist0202/gelsing/gelsing.htm

Gustavson J (1997) An insider's view of gene therapy. Bay Area Reporter 24 April 1997. http://www.hsph.harvard.edu/organizations/healthnet/HIV/docs/scimedoz/SciMed01354.html.

Hillman A (1996) Gene therapy: socioeconomic and ethical issues – a roundtable discussion. Human Gene Therapy 7, 1139–1144.

Lysaught T (1998) Commentary: reconstructing genetic research as research. Journal of Law, Medicine and Ethics 26(1): 48–54.

Martin P (1995) The American gene therapy industry and the social shaping of a new technology. Genetic Engineer and Biotechnologist 15: 155–167.

Mulligan RC (1993) The basic science of gene therapy. Science 260: 926–932.

Office of Inspector General, Department of Health and Human Services (1998) Institutional Review Boards: A Time for Reform. Washington, DC: US Government Printing Office.

http://oig.hhs.gov/oei/reports/oei‐01‐97‐00193.pdf

Orkin SH and Motulsky AG (1995) Report and Recommendations of The Panel to Assess the NIH Investment in Research on Gene Therapy. Report of the NIH, 7 December 1995. http://www.nih.gov/news/panelrep.html. Bethesda, MD: NIH.

Roehr B, Lappin D and Macklin R (2000) Supplemental comments and recommendations. In: Working Group on NIH Oversight of Clinical Gene Transfer Research Enhancing the Protection of Human Subjects in Gene Transfer Research at the National Institutes of Health, Appendix D. Report of the NIH, 12 July 2000. http://www.nih.gov/about/director/07122000.htm. Bethesda, MD: NIH.

Stockdale A (1999) Waiting for the cure: mapping the social relations of gene therapy research. Sociology of Health and Illness 21(5): 579–596.

Teitelman R (1989) Gene Dreams: Wall Street, Academia, and the Rise of Biotechnology. New York, NY: Basic Books.

Working Group on NIH Oversight of Clinical Gene Transfer Research (2000) Enhancing the Protection of Human Subjects in Gene Transfer Research at the National Institutes of Health. Report of the NIH, 12 July 2000. http://www.nih.gov/about/director/07122000.htm. Bethesda, MD: NIH.

Zallen DT (1996) Public oversight is necessary if human gene therapy is to progress. Human Gene Therapy 7: 795–797.

Further Reading

Caulfield T (2000) Underwhelmed: hyperbole, regulatory policy, and the genetic revolution. McGill Law Journal 45: 437–460.

King N (2002) RAC Oversight of gene transfer research: a model worth extending? Journal of Law, Medicine and Ethics 30: 381–389.

Web Links

Human Gene Therapy (Journal) http://www.humangenetherapy.com/hgt/

American Society for Gene Therapy http://www.asgt.org/

Recombinant DNA Advisory Committee http://www4.od.nih.gov/oba/Rdna.htm

Human Gene Therapy: Scope Note 24 http://www.georgetown.edu/research/nrcbl/scopenotes/sn24.html National Reference Center for Bioethics Literature, Georgetown University, Washington, DC

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Stockdale, Alan(Sep 2006) Gene Therapy: Motivations for Research. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0005655]